CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 144 enrolled
Drug / intervention
Dexmedetomidine and Midazolam +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03255824
NCT03255824Phase 4Completed
CompareCT.gov

A Comparison of Dexmedetomidine Versus Propofol for Use in Intravenous Sedation

Montefiore Medical Center·interventional·Posted Aug 21, 2017·Updated May 13, 2020

In Brief

A Phase 4 clinical trial evaluating Dexmedetomidine and Midazolam and Propofol, Midazolam, and Fentanyl for Anesthesia. Completed, enrolled 144 participants across 1 site.

Detailed Summary

Hypothesis: A combination of midazolam with dexmedetomidine for sedation during third molar surgery will provide 1) superior patient satisfaction, 2) superior operator satisfaction and 3) no significant hemodynamic or respiratory changes when compared to a sedation combination of midazolam, fentanyl and propofol for sedation during third molar surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnesthesia
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedAug 21, 2017
Enrollment StartMar 20, 2018
Primary CompletionAug 23, 2019
Study CompletionDec 27, 2019
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 8.9 years ago

Interventions

Dexmedetomidine and Midazolamdrug

Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.

Propofol, Midazolam, and Fentanyldrug

Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.